Liposome-encapsulated tumor necrosis factor-α enhances the effects of radiation against human colon tumor xenografts

Journal of Interferon and Cytokine Research

Volumn 21, Issue 11, 2001, Pages 885-897

  Kim, Dong W ^a   Andres, Melba L ^a   Li, Jun ^a   Kajioka, Eric H ^a   Miller, Glen M ^a   Seynhaeve, Ann L B ^b   Ten Hagen, Timo L M ^b   Gridley, Daila S ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLIPOSOME; MACROGOL; STEALTH; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL COUNT; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENCAPSULATION; ERYTHROCYTE COUNT; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFORMATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; BLOOD CELL COUNT; BODY WEIGHT; CELL DIVISION; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; HUMANS; IMMUNOPHENOTYPING; KINETICS; LIPOSOMES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, NUDE; ORGAN SIZE; RADIATION-SENSITIZING AGENTS; SPLEEN; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; MUS MUSCULUS;

EID: 0035674528     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999001753289497     Document Type: Article

References (34)

1. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin
2. Doxorubicin entrapped in sterically stabilized liposomes: Effects on bacterial blood clearance capacity of the mononuclear phagocyte system
3. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy
4. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma
5. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes
6. Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes
7. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue
8. Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes
9. Liposomes as carriers of cancer chemotherapy. Current status and future prospects
10. An endotoxin-induced serum factor that causes necrosis of tumors
11. Recombinant human tumor necrosis factor-alpha: Effects on proliferation of normal and transformed cells in vitro
12. Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: A summary of the Southwest Oncology Group experience
13. Shock and tissue injury induced by recombinant human cachectin
14. Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer
15. Regional application of TNF alpha in the treatment of cancer: A preclinical-clinical interactive program
16. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study
17. Stealth liposome technology: An overview
18. Biodistribution and tumor localization of Stealth liposomal tumor necrosis factor-alpha in soft tissue sarcoma bearing rats
19. Tumor necrosis factor-alpha augments radiation effects against human colon tumor xenografts
20. Interaction of tumour necrosis factor-alpha and radiation against human colon tumour cells
21. Evaluation of TNF-alpha effects on radiation efficacy in a human lung adenocarcinoma model
22. Tumor necrosis factor-alpha enhances antitumor effects of radiation against glioma xenografts
23. Surgical treatment of colorectal cancer
24. Topical issues in the treatment of rectal cancer: Economic and organizational aspects of concomitant radiochemotherapy
25. A pilot study of continuous, hyperfractionated, accelerated radiotherapy in rectal adenocarcinoma
26. Postoperative radiation therapy for high-risk colon carcinoma
27. Cancer statistics, 1999
28. Cancer statistics, 2000
29. Cigarette smoking and colorectal cancer mortality in the Cancer Prevention Study II
30. Low-dose tumor necrosis factor-alpha augments antitumor activity of Stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing rats
31. TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects
32. Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion
33. Immunotherapy and gene therapy of cancer